Not applicableStudy completedNCT03627546What this trial is testingHCV Seek, Test and Rapid Treatment for Young PWIDWho this might be right forHepatitis CDrug Use Weill Medical College of Cornell University 39
Not applicableUnknownNCT01944527What this trial is testingUse of Direct-acting Antiviral to Treat HCV Recurrence After Liver Transplantation (ANRSCO23CUPILT) InfectionWho this might be right forHCV RecurrenceLiver TransplantationDirect-acting Antiviral Agents ANRS, Emerging Infectious Diseases 699
Not applicableEnded earlyNCT05184283What this trial is testingUtilization of MAsS in Patients Undergoing LT for HCCWho this might be right forNAFLDHepatocellular CarcinomaLiver Diseases+3 more Columbia University 11
Large-scale testing (Phase 3)Study completedNCT00404651What this trial is testingLot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy InfantsWho this might be right forDiphtheriaTetanusPertussis+2 more Sanofi Pasteur, a Sanofi Company 1,189
Large-scale testing (Phase 3)Study completedNCT00469131What this trial is testingEffects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + SteroidWho this might be right forHepatitis CLiver Cirrhosis Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 79
Not applicableStudy completedNCT04029454What this trial is testingNeovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vaccine Into the Infant Immunization ScheduleWho this might be right forHepatitis B Institut Pasteur 10,000
Large-scale testing (Phase 3)Study completedNCT00040027What this trial is testingThymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus RibavirinWho this might be right forHepatitis CHepatitis C, Chronic SciClone Pharmaceuticals 500
Testing effectiveness (Phase 2)UnknownNCT05382351What this trial is testingAntiviral Therapy for Patients With Chronic Hepatitis B InfectionWho this might be right forChronic Hepatitis B Virus Infection Sun Yat-sen University 238
Early research (Phase 1)Looking for participantsNCT07557251What this trial is testingEvaluate the Safety, Tolerability, and Preliminary Efficacy of BRII-5395 in Combination With Sintilimab and Bevacizumab in Advanced Hepatitis B Virus Related Hepatocellular CarcinomaWho this might be right forAdvanced HBV-Related Hepatocellular Carcinoma Cancer Institute and Hospital, Chinese Academy of Medical Sciences 21
Post-approval studies (Phase 4)UnknownNCT01683786What this trial is testing36 vs 48 Wks Peg-Intron Plus Ribavirin for HCV Patients Without Rapid Virologic Response But Without HCV RNA at wk 8Who this might be right forHepatitis C Infection Chang Gung Memorial Hospital 60
Not applicableLooking for participantsNCT06802731What this trial is testingLivQ-box® Parameters in the Diagnosis of Liver InflammationWho this might be right forLiver InflammationFatty Liver Disease Wuxi Hisky Medical Technology Co Ltd 365
Post-approval studies (Phase 4)WithdrawnNCT02135666What this trial is testingEvaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084)Who this might be right forHepatitis BHepatitis A GlaxoSmithKline
Early research (Phase 1)Study completedNCT01817985What this trial is testingEvaluate the Pharmacokinetics of GS-5816 in Subjects With Normal Hepatic Function and Moderate or Severe Hepatic ImpairmentWho this might be right forChronic Hepatitis C Gilead Sciences 33
Early research (Phase 1)Study completedNCT00389376What this trial is testingPhase I Trial of Silymarin for Chronic Liver DiseasesWho this might be right forHepatitis CNon-Alcoholic Fatty Liver Disease National Center for Complementary and Integrative Health (NCCIH) 56
Large-scale testing (Phase 3)Study completedNCT01513850What this trial is testingA Confirmatory Study of Hepabulin IV in HBsAg Positive Liver Transplantation RecipientsWho this might be right forHepatitis B SK Chemicals Co., Ltd. 87
Testing effectiveness (Phase 2)Study completedNCT02300103What this trial is testingEfficacy And Safety Of Sofosbuvir/Velpatasvir Fixed Dose Combination With Ribavirin in Chronic HCV Infected Adults Who Participated in a Prior Gilead Sponsored HCV Treatment StudyWho this might be right forHepatitis C Virus Infection Gilead Sciences 69
Large-scale testing (Phase 3)Study completedNCT00371761What this trial is testingPegIntron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan (P04498/MK-4031-278)Who this might be right forHepatitis B, Chronic (CHB) Merck Sharp & Dohme LLC 25
Testing effectiveness (Phase 2)Study completedNCT00418054What this trial is testingStudy of Nitazoxanide Combined With Peginterferon Compared to Peginterferon Monotherapy in the Treatment of Hepatitis CWho this might be right forChronic Hepatitis C Romark Laboratories L.C. 40
Large-scale testing (Phase 3)Study completedNCT02596880What this trial is testingSofosbuvir, Daclatasvir, Ribavirin for Hepatitis C Virus (HCV) CirrhoticsWho this might be right forHepatitis CCirrhosis Tehran University of Medical Sciences 100
Post-approval studies (Phase 4)UnknownNCT02802280What this trial is testingEndothelial Dysfunction and Subclinical Atheromatosis in Chronic HCV Infection. Response to DAA Agents.Who this might be right forHepatitis CCardiovascular Diseases Instituto de Investigación Marqués de Valdecilla 80